Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from CapsoVision, Inc. ( (CV) ).
On July 15, 2025, CapsoVision, Inc. entered into a development agreement with Canon Inc. to create CMOS image sensor samples for future versions of its capsule endoscopies, with a development fee of approximately $4.1 million. Additionally, on July 16, 2025, the company raised approximately $600,000 through an overallotment exercise of its initial public offering, issuing additional shares and warrants, which are subject to a 180-day restriction period.
More about CapsoVision, Inc.
CapsoVision, Inc. operates in the medical technology industry, specializing in capsule endoscopy solutions. The company offers products like CapsoCam Plus for small bowel examinations and is advancing its CapsoCam Colon for large bowel diagnostics, with a focus on obtaining FDA clearances for its innovations.
Average Trading Volume: 1,104,172
Find detailed analytics on CV stock on TipRanks’ Stock Analysis page.